NCT04411823View on ClinicalTrials.gov

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Gastroesophageal RefluxSleeve GastrectomyBariatric Surgery Complication
Interventions
DEVICE

EndoFLIP measurement

EndoFLIP device can measure gastroesophageal junction distensibility index and esophageal contractile pattern under FDA cleared indication. It is performed during endoscopy.

Trial Locations (2)

32806

ACTIVE_NOT_RECRUITING

Orlando Health, Orlando

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04411823 - Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction | Biotech Hunter | Biotech Hunter